Preconditioning Serum Levels of Endothelial Cell-Derived Molecules and the Risk of Posttransplant Complications in Patients Treated with Allogeneic Stem Cell Transplantation
Table 1
Clinical and biological characteristics of allotransplanted patients included in the study.
Age (years, median, and range)
43 (18–63)
Gender
Males
38
Females
18
Diagnosis
AML
33
B-ALL
11
T-ALL
4
MDS
2
CMML
2
CML
1
Myelofibrosis secondary to polycythemia vera
1
Aplastic anemia
2
Status at the time of transplantation
First complete hematological remission
41
Second or later complete remission
8
Previous allogeneic stem cell transplantation and now complete remission
1
Detectable disease
6
Conditioning therapy
Busulfan + cyclophosphamide
52
Total body irradiation + cyclophosphamide
1
Antithymocyte globulin + cyclophosphamide
2
BEAM (carmustine, etoposide, cytarabine, and melphalan)
1
Stem cell grafts
Peripheral blood mobilized stem cells
54
Bone marrow
2
GVHD prophylaxis with cyclosporin A plus methotrexate
